Axogen, Inc. (AXGN)
AXGN moved a median of -0.12% 30 minutes after news, and +0.12% by the close. How AXGN actually reacts to news — the realized, point-in-time move the market made, measured across 393 labeled events over the last three years with zero look-ahead.
AXGN’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 49% | 393 |
| 30-min | -0.12% | 48% | 393 |
| 60-min | -0.06% | 43% | 393 |
| to close | +0.12% | 53% | 392 |
| Middle 50% of AXGN reactions | -0.93% to +0.92% |
|---|---|
| Median reaction (30-min) | -0.12% |
| Measured reactions | 393 |
Half of all Axogen, Inc. news events land between -0.93% and +0.92% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How AXGN reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades | 13 | +0.82% | 69% | +1.87% |
| Coverage initiations | 17 | -0.27% | 41% | +2.80% |
| Rating reiterations | 53 | +0.14% | 53% | +0.05% |
| Price-target raises | 13 | -0.60% | 23% | -1.00% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 2 further classes were observed with fewer than 10 measured events and are not published. See how AXGN ranks against every other measured name →
That’s how AXGN usually reacts — get an email when it moves on news →Email me when AXGN moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to AXGN's baseline. Nothing else.
Recent AXGN events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape™, the First FDA Cleared Device for Sutureless Peripheral Nerve Repair | Press release | GlobeNewswire | -2.17% | -6.34% | |
| Form 8-K Axogen, Inc. For: Oct 01 | SEC filing · Form 8-K | SEC EDGAR | -2.17% | -6.34% | |
| Axogen Announces Pricing of $208.7 Million Public Offering of Common Stock | Press release | GlobeNewswire | -4.71% | -7.88% | |
| Axogen Enters into Definitive Agreement to Acquire BioCircuit Technologies | Press release | GlobeNewswire | -4.71% | -7.88% | |
| Form 8-K Axogen, Inc. For: Sep 09 | SEC filing · Form 8-K | SEC EDGAR | -4.71% | -7.88% | |
| Form 8-K/A Axogen, Inc. For: Sep 09 | SEC filing · Form 8-K | SEC EDGAR | -0.20% | -0.75% | |
| Axogen, Inc. to Participate in the 24th Annual Morgan Stanley Global Healthcare Conference | Press release | GlobeNewswire | +0.17% | -1.50% | |
| Axogen, Inc. Reports Second Quarter 2026 Financial Results | Press release | GlobeNewswire | +10.13% | +7.99% | |
| Form 10-Q Axogen, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +6.54% | +1.32% | |
| Form 8-K Axogen, Inc. For: Jul 29 | SEC filing · Form 8-K | SEC EDGAR | +10.13% | +7.99% | |
| Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology | Press release | PR Newswire | +10.13% | +7.99% | |
| Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026 | Press release | GlobeNewswire | -0.01% | -0.44% | |
| Form 8-K Axogen, Inc. For: Jun 23 | SEC filing · Form 8-K | SEC EDGAR | -0.69% | -5.20% | |
| The Newest Name on Nasdaq Wants to Help the Body Rebuild Itself | Press release | GlobeNewswire | +0.20% | -0.22% | |
| Axogen, Inc. to Participate in the 2026 Bank of America Global Healthcare Conference | Press release | GlobeNewswire | -0.69% | +2.15% | |
| Form ARS Axogen, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | -0.69% | +2.15% | |
| Form DEF 14A Axogen, Inc. For: Dec 31 | SEC filing · Form DEF | SEC EDGAR | -0.69% | +2.15% | |
| Axogen, Inc. Reports First Quarter 2026 Financial Results | Press release | GlobeNewswire | +1.36% | -2.35% | |
| Form 10-Q Axogen, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | +0.48% | +1.36% | |
| Form 8-K Axogen, Inc. For: Apr 28 | SEC filing · Form 8-K | SEC EDGAR | +1.36% | -2.35% | |
| Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026 | Press release | GlobeNewswire | +2.05% | +2.25% | |
| Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results | Press release | GlobeNewswire | +8.04% | +9.72% | |
| Form 10-K Axogen, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.09% | -2.31% | |
| Form 8-K Axogen, Inc. For: Feb 24 | SEC filing · Form 8-K | SEC EDGAR | +8.04% | +9.72% | |
| Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences | Press release | GlobeNewswire | +1.60% | +3.40% | |
| Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026 | Press release | GlobeNewswire | +0.23% | +1.35% | |
| Form 8-K Axogen, Inc. For: Jan 21 | SEC filing · Form 8-K | SEC EDGAR | +0.81% | +2.95% | |
| Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock | Press release | GlobeNewswire | -0.53% | -0.31% | |
| Axogen Announces Proposed Public Offering of Common Stock | Press release | GlobeNewswire | -0.53% | -0.31% | |
| Form S-3ASR Axogen, Inc. | SEC filing · Form S-3ASR | SEC EDGAR | -0.53% | -0.31% | |
| Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025 | Press release | GlobeNewswire | -1.38% | -5.68% | |
| Form 8-K Axogen, Inc. For: Jan 12 | SEC filing · Form 8-K | SEC EDGAR | -1.38% | -5.68% | |
| Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference | Press release | GlobeNewswire | +1.75% | +5.90% | |
| Form 8-K Axogen, Inc. For: Dec 03 | SEC filing · Form 8-K | SEC EDGAR | -1.18% | -6.78% | |
| Form 8-K Axogen, Inc. For: Dec 03 | SEC filing · Form 8-K | SEC EDGAR | -0.10% | +5.75% | |
| Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx) | Press release | GlobeNewswire | -0.10% | +5.75% | |
| Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences | Press release | GlobeNewswire | +1.19% | +3.08% | |
| Axogen, Inc. Reports Third Quarter 2025 Financial Results | Press release | GlobeNewswire | +1.48% | +17.60% | |
| Form 10-Q Axogen, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -3.75% | -1.00% | |
| Form 8-K Axogen, Inc. For: Oct 29 | SEC filing · Form 8-K | SEC EDGAR | +1.48% | +17.60% | |
| Bronstein, Gewirtz & Grossman, LLC Is Investigating Axogen, Inc. (AXGN) And Encourages Shareholders to Connect | Press release | ACCESS Newswire | +0.89% | +1.13% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Axogen, Inc. (AXGN) And Encourages Shareholders to Reach Out | Press release | ACCESS Newswire | +0.80% | +2.09% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Axogen, Inc. (AXGN) and Encourages Shareholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.21% | -0.74% | |
| Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025 | Press release | GlobeNewswire | +1.75% | +1.07% | |
| Axogen, Inc. (AXGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation | Press release | ACCESS Newswire | +0.40% | -3.05% | |
| Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Axogen, Inc. (AXGN) and Encourages Stockholders to Learn More About the Investigation | Press release | ACCESS Newswire | +0.06% | -3.58% | |
| Bronstein, Gewirtz & Grossman, LLC Encourages Axogen, Inc. (AXGN) Investors to Inquire about Securities Investigation | Press release | ACCESS Newswire | -0.13% | -4.53% | |
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Axogen, Inc. (AXGN) And Encourages Stockholders to Reach Out | Press release | ACCESS Newswire | +0.19% | -1.54% | |
| Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences | Press release | GlobeNewswire | +0.25% | -0.12% | |
| Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft | Press release | GlobeNewswire | -3.12% | +3.79% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the AXGN section they belong to.
Where else AXGN is measured.
AXGN earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Bruker Corporation (BRKR) | 395 | -0.10% | 46% |
| Neuronetics, Inc. (STIM) | 395 | -0.21% | 45% |
| Fulgent Genetics, Inc. (FLGT) | 393 | +0.04% | 51% |
| Kazia Therapeutics Limited - American Depositary Shares (KZIA) | 393 | -1.07% | 34% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Axogen, Inc.'s median reaction calculated?
Every labeled AXGN news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 393 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 48% of AXGN's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does AXGN's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.